CURE vs UAPR

Comparison between DIREXION DAILY HEALTHCARE BULL 3X SHARES (CURE, ETF) and Innovator U.S. Equity Ultra Buffer ETF - April (UAPR, ETF).

5-Year PerformanceUAPR has outperformed CURE, delivering a return of +6.4% compared to +2.3%

CURE vs UAPR - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	CURE(ETF)	UAPR(ETF)
Net Assets	$157M	$156M
Expense Ratio	N/A	0.79%
Max Drawdown	69.19%	14.61%
Sharpe Ratio	0.79	2.82
5Y Beta	1.38	0.42
P/E Ratio	28.04	N/A
Forward P/E	18.09	N/A
5Y Dividends CAGR	63.21%	N/A
5Y EPS CAGR	12.58%	N/A
Debt to Equity	53.58%	N/A
P/S Ratio	1.48	N/A
P/B Ratio	4.58	N/A

Net Assets

Winner

CURE

$157M

UAPR

$156M

Expense Ratio

CURE

N/A

UAPR

0.79%

Max Drawdown

CURE

69.19%

Winner

UAPR

14.61%

Sharpe Ratio

CURE

0.79

Winner

UAPR

2.82

5Y Beta

CURE

1.38

Winner

UAPR

0.42

P/E Ratio

CURE

28.04

UAPR

N/A

Forward P/E

CURE

18.09

UAPR

N/A

5Y Dividends CAGR

CURE

63.21%

UAPR

N/A

5Y EPS CAGR

CURE

12.58%

UAPR

N/A

Debt to Equity

CURE

53.58%

UAPR

N/A

P/S Ratio

CURE

1.48

UAPR

N/A

P/B Ratio

CURE

4.58

UAPR

N/A

CURE vs UAPR - Historical Returns

Returns include dividend reinvestment.

Period	CURE	UAPR
1 month	+22.71%	+0.15%
3 months	-2.64%	+5.39%
6 months	+3.17%	+7.01%
1 year	+35.83%	+13.05%
5 years(CAGR)	+2.35%	+6.41%
10 years(CAGR)	+13.12%	N/A
Max(CAGR)	+23.37%	+4.94%

Winner

CURE

+22.71%

UAPR

+0.15%

CURE

-2.64%

Winner

UAPR

+5.39%

CURE

+3.17%

Winner

UAPR

+7.01%

Winner

CURE

+35.83%

UAPR

+13.05%

5Y(CAGR)

CURE

+2.35%

Winner

UAPR

+6.41%

10Y(CAGR)

CURE

+13.12%

UAPR

N/A

Max(CAGR)

Winner

CURE

+23.37%

UAPR

+4.94%

CURE vs UAPR - Annual Returns (2011 - 2026)

Returns include dividend reinvestment.

Year	CURE	UAPR
2026	-7.73%	+6.18%
2025	+22.87%	+6.38%
2024	-12.90%	+12.50%
2023	-8.46%	+10.69%
2022	-17.91%	-5.59%
2021	+90.55%	+5.58%
2020	+4.13%	-5.32%
2019	+62.36%	+6.74%
2018	-0.75%	N/A
2017	+62.77%	N/A
2016	-12.42%	N/A
2015	+6.24%	N/A
2014	+83.03%	N/A
2013	+153.15%	N/A
2012	+45.79%	N/A
2011	-9.68%	N/A

CURE vs UAPR Drawdown Comparison

The maximum drawdown for CURE was -69.19%, occurring on Mar 23, 2020. Recovery took 242 trading sessions.

The maximum drawdown for UAPR was -14.61%, occurring on Apr 1, 2020. Recovery took 945 trading sessions.

The current CURE drawdown is -25.85%. The current UAPR drawdown is -0.72%.

Rank	CURE	UAPR
#1	-69.19% Jan 22, 2020 - Jan 6, 2021	-14.61% Feb 19, 2020 - Nov 17, 2023
#2	-52.25% Apr 8, 2022 - Aug 7, 2025	-10.84% Feb 19, 2025 - Aug 18, 2025
#3	-48.54% Jul 20, 2015 - Jun 22, 2017	-4.49% Jul 16, 2024 - Aug 21, 2024
#4	-44.44% Jul 1, 2011 - Mar 15, 2012	-3.23% Apr 29, 2019 - Jun 20, 2019
#5	-42.27% Oct 1, 2018 - Nov 27, 2019	-2.98% Mar 28, 2024 - May 15, 2024
#6	-36.35% Jan 26, 2018 - Sep 13, 2018	-2.75% Jul 26, 2019 - Sep 12, 2019
#7	-29.28% Dec 30, 2021 - Apr 8, 2022	-2.48% Aug 30, 2024 - Sep 19, 2024
#8	-22.89% Aug 17, 2021 - Dec 15, 2021	-1.77% Sep 12, 2019 - Oct 15, 2019
#9	-22.59% Sep 24, 2014 - Oct 28, 2014	-1.61% Dec 11, 2024 - Jan 17, 2025
#10	-19.78% Mar 4, 2014 - Jun 19, 2014	-1.35% Oct 22, 2024 - Nov 6, 2024
#11	-19.31% Oct 17, 2012 - Jan 9, 2013	-0.97% Oct 28, 2025 - Nov 25, 2025
#12	-19.31% Jan 20, 2021 - Apr 15, 2021	-0.91% May 21, 2024 - Jun 5, 2024
#13	-17.38% Apr 2, 2012 - Jun 29, 2012	-0.86% Nov 27, 2019 - Dec 12, 2019
#14	-15.49% May 28, 2013 - Jul 12, 2013	-0.81% Nov 13, 2024 - Nov 22, 2024
#15	-14.96% Dec 8, 2014 - Jan 22, 2015	-0.78% Jan 17, 2020 - Feb 5, 2020

Correlation

Correlation between CURE and UAPR is 0.39 which considered as a weak positive correlation - the stocks show a slight tendency to move together.

0.39

-101

Dividend Comparison (2011 - 2026)

CURE vs UAPR dividend yield comparison.

Year	CURE	UAPR
2026	0.27%	0.00%
2025	1.12%	0.00%
2024	1.17%	0.00%
2023	2.02%	0.00%
2022	0.38%	0.00%
2021	0.02%	0.00%
2020	0.17%	0.00%
2019	0.40%	2.17%
2018	0.70%	0.00%
2017	0.18%	0.00%
2013	1.24%	0.00%
2012	0.03%	0.00%
2011	2.10%	0.00%